Physician profile
Claudia Baxter
NPI 1780654897
$6,605.76
in general payments reported to CMS, 2019-2025
33 companies · $708 in 2025
The $708 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,532 · 2020: $328 · 2021: $671 · 2022: $1,400 · 2023: $1,099 · 2024: $866 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,670 · Education: $4.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,669.76 |
| Education | $4.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,472.34 | 2019-2024 | Lo Loestrin Fe, Ubrelvy, Qulipta |
| Astellas Pharma US INC | $607.85 | 2019-2025 | Veozah, Myrbetriq |
| Amgen INC. | $570.34 | 2019-2025 | Evenity, Prolia, Prolia |
| Gen-Probe, INC. | $557.77 | 2019 | |
| Mayne Pharma Commercial LLC | $500.57 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $343.25 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $315.37 | 2019-2024 | |
| Therapeuticsmd, INC. | $302.39 | 2019-2022 | |
| Exact Sciences Corporation | $236.86 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $206.92 | 2019-2025 | |
| Lupin INC. | $157.19 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $143.16 | 2020-2025 | Gardasil 9 |
| Vertical Pharmaceuticals, LLC | $132.45 | 2019-2020 | |
| Evofem Biosciences, INC. | $104.71 | 2022 | |
| Coopersurgical, INC. | $102.67 | 2019-2025 | Paragard T 380a |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $91.37 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $84.55 | 2024 | Slynd |
| Amag Pharmaceuticals, INC. | $76.43 | 2019-2020 | |
| Urovant Sciences INC | $72.50 | 2022 | |
| Myovant Sciences INC. | $68.63 | 2021-2022 | |
| Duchesnay USA Incorporated | $67.91 | 2019 | |
| Organon LLC | $50.27 | 2022-2023 | Nexplanon |
| Daiichi Sankyo INC. | $48.24 | 2019-2024 | Injectafer |
| Convatec INC. | $44.77 | 2023-2024 | |
| Smith+Nephew, INC. | $41.69 | 2022-2023 | Pico 7 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.64 | 2023 | Xifaxan |
| Hologic Sales and Service, LLC | $34.48 | 2022-2025 | Omni Hysteroscope |
| Allergan, INC. | $33.02 | 2019 | |
| Avion Pharmaceuticals | $22.67 | 2021 | |
| Millicent US INC | $21.10 | 2025 | Femlyv |
| Glaxosmithkline, LLC. | $20.16 | 2025 | Nucala |
| Mylan Pharmaceuticals INC. | $19.32 | 2021 | |
| Agile Therapeutics, INC. | $14.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudia Baxter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.